Abiological Self-Assembly
Abiological Self-Assembly
批准号:
8180793
负责人:
Peter J Stang
金额:
$18.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-01-01 至 2013-08-31
关键词:
AffinityAntifreeze ProteinsAntineoplastic AgentsBindingBiochemicalBiologicalBiological ProcessCell surfaceChemical AgentsChemistryCilengitideComplementComplexCyclophosphamideDiseaseDoxorubicinDrug Delivery SystemsEndotheliumEnzymesFluorouracilFutureGene Expression RegulationGoalsGrantHeartHumanIn VitroIntegrinsInvestigationKineticsLifeLigandsLiteratureMedicalMembraneMetalsMethodologyMethodsMicrotubulesModelingNucleic AcidsOrganismPharmaceutical PreparationsPhospholipidsPreparationPreventionProcessProductionProgress ReportsPropertyProteinsPublishingResearchResearch PersonnelRibosomesShapesSpecificityStructureSystemThermodynamicsTransfectionantitumor agentbasechemotherapychymotrypsindesignimprovedinnovationinsightmolecular recognitionnanoscalenovelnovel strategiesprotein foldingrepairedself assemblysmall moleculetooltumor
中文摘要
描述(由申请人提供):这项研究的长期目标是:(1)通过合理的设计,利用非生物自组装,开发高效、新的方法来制备形状和尺寸定义良好的复杂纳米分子;(2)提供见解并更好地了解分子识别现象和自组装过程;(3)开发非生物自组装,作为新的生物医学应用的平台。[我们的具体目标是:(A)研究类药物有机小分子的包裹和主客体相互作用,以及三种不同的、广泛使用的商业抗癌药物(氟尿嘧啶、环磷酰胺、阿霉素)的包裹;(B)通过预先设计的自组装金属载体研究蛋白质和酶的包裹;(C)通过自组装金属载体和肽(和其他)整合素拮抗剂的多价展示,开发靶向给药方法。]我们将使用非生物、协调驱动和我们的“定向结合”方法来实现这些目标。这种方法允许快速、预先设计的、(合理的)自组装具有定义良好的形状和大小的纳米系统,这是因为金属d轨道的参与使得配位的金属-配体键具有高度的方向性。此外,可以调节配位动力学以进行自我修复,以实现对所需的、预先设计的超级结构的热力学控制。自组装是无数生物过程的核心,所有活着的有机体,从最简单的到人类,都依赖于此。蛋白质折叠、核酸组装和三级结构、核糖体、磷脂膜和微管只是自组装的典型例子。从拟议的非生物自组装研究中获得的见解将适用于更好和更完整地理解复杂的、尚未被很好理解的生物自组装过程。如果这一应用的目标得以实现,生物医学研究人员将拥有新的工具和全新的方法来形成具有独特性质的大的纳米级复杂分子,这些分子将补充和增强传统的共价合成方法。因此,从长远来看,这些方法将促进发现和生产改进的化学制剂和化疗,用于治疗和可能预防医疗疾病。
与公共健康相关:如果这一应用的目标得以实现,生物医学研究人员将拥有新的工具和全新的方法来形成具有独特性质的大的纳米级复杂分子,这些分子将补充和增强传统的共价合成方法。因此,从长远来看,这些方法将促进发现和生产改进的化学制剂和化疗,用于治疗和可能预防医疗疾病,特别是。此外,在未来,创新的转基因系统和可能的基因调控可能会从这些发现中进化出来。
英文摘要
DESCRIPTION (provided by applicant): The broad long term objectives of this research are: (1) to develop efficient, new methods for the preparation of complex nanoscale molecules with well-defined shapes and sizes, by rational design, using abiological self- assembly; (2) to provide insights and gain a better understanding of molecular recognition phenomena and self-assembly processes; (3) to develop abiological self-assembly as a platform for novel biomedical applications. [Our specific goals are to: (a) examine encapsulation and host-guest interactions of small drug- like organic molecules, as well as the encapsulation of three diverse, widely-used commercially-available cancer drugs (fluorouracil, cyclophosphamide, doxorubicin); (b) study protein and enzyme encapsulation by pre-designed self-assembled metallacages; (c) develop targeted drug delivery methodologies via self- assembled metallacages and the multivalent display of peptidic (and other) integrin antagonists.] We will use abiological, coordination-driven and our "directional bonding" approach to achieve these aims. This methodology allows for the rapid, pre-designed, (rational) self-assembly of nanoscale systems with well- defined shapes and sizes, due to metal d-orbital involvement that allows dative, metal-ligand bonds to be highly directional. Moreover, coordination kinetics can be modulated to engage in self-repair to achieve thermodynamic control of the desired, pre-designed super structures. Self-assembly is at the heart of countless biological processes that all living organisms, from the simplest to humans, depend upon. Protein folding, nucleic acid assembly and tertiary structures, ribosomes, phospholipid membranes and microtubules are but representative examples of self-assembly. Insights gained from the proposed abiological self-assembly studies will be applicable to a better and more complete understanding of the complex, not well-understood biological self-assembly processes. If the aims of this application are achieved, biomedical researchers will have new tools and entirely new approaches for the formation of large, nanoscale, complex molecules with unique properties that will complement and enhance classical covalent synthetic methods. As a consequence, in the long term, these approaches will facilitate the discovery and production of improved chemical agents and chemotherapy for the treatment and possible prevention of medical disorders.
PUBLIC HEALTH RELEVANCE: If the aims of this application are achieved, biomedical researchers will have new tools and entirely new approaches for the formation of large, nanoscale, complex molecules with unique properties that will complement and enhance classical covalent synthetic methods. As a consequence, in the long term, these approaches will facilitate the discovery and production of improved chemical agents and chemotherapy for the treatment and possible prevention of medical disorders and in particular. Additionally, in the future, innovative transfection systems and possible gene-regulation may evolve from these discoveries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I.Iodonium Chemistry. II. Abiological Self-Assembly
-
批准号:6629414
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
I.Iodonium Chemistry. II. Abiological Self-Assembly
-
批准号:7344653
-
项目类别:
-
资助金额:$9.97万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
POLYVALENT IODINE AND DERIVED CHEMISTRY
-
批准号:6343004
-
项目类别:
-
资助金额:$30.32万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
ABIOLOGICAL SELF-ASSEMBLY
-
批准号:7251610
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
ABIOLOGICAL SELF-ASSEMBLY
-
批准号:7765584
-
项目类别:
-
资助金额:$29.6万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
ABIOLOGICAL SELF-ASSEMBLY
-
批准号:7415151
-
项目类别:
-
资助金额:$29.9万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
I.Iodonium Chemistry. II. Abiological Self-Assembly
-
批准号:6929759
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
POLYVALENT IODINE AND DERIVED CHEMISTRY
-
批准号:2468132
-
项目类别:
-
资助金额:$24.9万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
POLYVALENT IODINE AND DERIVED CHEMISTRY
-
批准号:6339636
-
项目类别:
-
资助金额:$1.9万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
Abiological Self-Assembly
-
批准号:8335374
-
项目类别:
-
资助金额:$18.68万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
I.Iodonium Chemistry. II. Abiological Self-Assembly
-
批准号:6789921
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
ABIOLOGICAL SELF-ASSEMBLY
-
批准号:7575602
-
项目类别:
-
资助金额:$29.9万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
POLYVALENT IODINE AND DERIVED CHEMISTRY
-
批准号:6138639
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
I.Iodonium Chemistry. II. Abiological Self-Assembly
-
批准号:6503347
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
POLYVALENT IODINE AND DERIVED CHEMISTRY
-
批准号:2857359
-
项目类别:
-
资助金额:$23.27万
-
财政年份:1998
-
负责人:Peter J Stang
-
依托单位:
FLUORINATED BIOCOMPOUNDS VIA I SALTS & RELATED CHEMISTRY
-
批准号:6199677
-
项目类别:
-
资助金额:$3.85万
-
财政年份:1995
-
负责人:Peter J Stang
-
依托单位:
10 ELECTRON ELECTROPHILIC FLUORINATING AGENTS
-
批准号:2380066
-
项目类别:
-
资助金额:$2.41万
-
财政年份:1995
-
负责人:Peter J Stang
-
依托单位:
10 ELECTRON ELECTROPHILIC FLUORINATING AGENTS
-
批准号:2292047
-
项目类别:
-
资助金额:$2.41万
-
财政年份:1995
-
负责人:Peter J Stang
-
依托单位:
FLUORINATED BIOCOMPOUNDS VIA I SALTS & RELATED CHEMISTRY
-
批准号:6394908
-
项目类别:
-
资助金额:$3.85万
-
财政年份:1995
-
负责人:Peter J Stang
-
依托单位:
10 ELECTRON ELECTROPHILIC FLUORINATING AGENTS
-
批准号:2292046
-
项目类别:
-
资助金额:$2.41万
-
财政年份:1995
-
负责人:Peter J Stang
-
依托单位:
海外基金